Tocqueville Asset Management L.P. Axsome Therapeutics, Inc. Transaction History
Tocqueville Asset Management L.P.
- $6.27 Billion
- Q3 2024
A detailed history of Tocqueville Asset Management L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 5,100 shares of AXSM stock, worth $408,255. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,100
Previous 5,200
1.92%
Holding current value
$408,255
Previous $418,000
9.57%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$335 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$264 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$189 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$83.7 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.43B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...